Huahai Pharmaceutical convertible bonds near downward conversion price revision trigger

Zhejiang Huahai Pharmaceutical's convertible bonds, "Huahai Convertible Bonds" (Code: 110076), are expected to trigger a downward revision of their conversion price. The current conversion price is 33.06 yuan per share. The company's stock traded below 80% of this price for 10 trading days between October 16, 2025, and October 29, 2025, reaching 26.45 yuan per share.

The company previously announced on August 16, 2025, that it would not correct the conversion price for "Huahai Convertible Bonds." According to regulatory guidelines, if the trigger conditions are met, the company will convene a board meeting on the trigger date to decide whether to amend the conversion price and will promptly disclose its decision.

The "Huahai Convertible Bonds" were publicly issued on November 2, 2020, with a total value of 1.8426 bn yuan across 18.426 m bonds, each with a face value of 100.00 yuan. The bonds began trading on the Shanghai Stock Exchange on November 25, 2020, and have a six-year term from their issuance date.